Novotech Featured Reports

  1. Ovarian Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/8/2023

    Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  2. Why You Should Conduct Your Biotech And CAR-T Research In China 4/5/2023

    China is leading the world in oncology and CAR-T research. And with over a billion people and a government friendly to biotech, it’s an ideal location for international clinical trials.

  3. Designing A Global Drug Development Program To Secure FDA Approval 2/7/2023

    Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.

  4. Leveraging Global Drug Development Programs To Ensure Trial Success 2/7/2023

    Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.

  5. Parkinson's Disease: Asia Pacific Clinical Trial Landscape 9/29/2022

    In the coming years, the global burden of Parkinson's Disease (PD) is expected to rise. The number of people with PD in Asia is anticipated to exceed 6 million by 2030. Discover the factors leading to this in this report.

  6. Multiple Myeloma: Asia Pacific Clinical Trial Landscape 9/29/2022
  7. COVID-19: Asia Pacific Clinical Trial Landscape 9/29/2022

    In December 2019, a novel coronavirus was discovered in China causing severe acute respiratory syndrome-like pneumonia which resulted in a pandemic. Find out more details regarding its spread in this report.

  8. Solid Tumors: Asia Pacific Clinical Trial Landscape 9/29/2022

    Read more about how the large population and lower volume of studies decreases competing trial risk in this region with a great need for novel drug therapies for solid tumors in Asian patients

  9. Psoriasis: Asia Pacific Clinical Trial Landscape 9/29/2022

    Psoriasis can have a significant psychological effect on both the patient and their family. Explore the cultural factors, socioeconomic factors, and higher levels of social stigma and prejudice resulting that make this disease more prevalent in Asia.

  10. Diffuse Large B-Cell Lymphoma: Asia Pacific Clinical Trial Landscape 9/29/2022

    DLBCL is the most prevalent Non-Hodgkin Lymphoma (NHL) which accounts for about 30%-40% of all NHL cases worldwide. Explore its prevalence in the Asia Pacific region in this report.